Skip to main navigation
Decibel Therapeutics logo
Menu Button

Top Menu

  • JOIN US
  • CONTACT US

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
August 17, 2021 8-K

Report of unscheduled material events or corporate event

0001193125-21-249253.pdf
0001193125-21-249253.rtf
0001193125-21-249253.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

0001564590-21-042863.pdf
0001564590-21-042863.rtf
0001564590-21-042863.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 3, 2021 8-K

Report of unscheduled material events or corporate event

0001193125-21-181348.pdf
0001193125-21-181348.rtf
0001193125-21-181348.xls
View HTML
June 3, 2021 3

Initial filing by director officer or owner of more than ten percent.

0000899243-21-021806.pdf
0000899243-21-021806.rtf
0000899243-21-021806.xls
View HTML
June 3, 2021 4

Statement of changes in beneficial ownership of securities

0000899243-21-021812.pdf
0000899243-21-021812.rtf
0000899243-21-021812.xls
View HTML
May 13, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

0001564590-21-027531.pdf
0001564590-21-027531.rtf
0001564590-21-027531.xls
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
April 13, 2021 8-K

Report of unscheduled material events or corporate event

0001193125-21-114755.pdf
0001193125-21-114755.rtf
0001193125-21-114755.xls
View HTML
March 29, 2021 8-K

Report of unscheduled material events or corporate event

0001193125-21-098284.pdf
0001193125-21-098284.rtf
0001193125-21-098284.xls
View HTML
March 29, 2021 10-K

Annual report which provides a comprehensive overview of the company for the past year

0001564590-21-016167.pdf
0001564590-21-016167.rtf
0001564590-21-016167.xls
View HTML
March 8, 2021 4

Statement of changes in beneficial ownership of securities

0001062993-21-002471.pdf
0001062993-21-002471.rtf
0001062993-21-002471.xls
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page Next ›
  • Last page Last »
Displaying 51 - 60 of 119 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2023. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us